Defiance ETFs’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Defiance ETFs's VRTX Position: Q2 2026 in Review
Defiance ETFs increased its Vertex Pharmaceuticals (VRTX) stake by 19% in Q2 2026, buying an estimated $70.9K and bringing the position to 1,000 shares worth $498K. The position accounts for 0.01% of the portfolio, ranked #278.
Defiance ETFs first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Defiance ETFs held 1,000 shares of Vertex Pharmaceuticals worth $498K as of Q2 2026.
- Defiance ETFs bought 160 Vertex Pharmaceuticals shares in Q2 2026, an estimated $70.9K.
- Vertex Pharmaceuticals made up 0.01% of Defiance ETFs's portfolio in Q2 2026, its #278 holding.
- Defiance ETFs first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.